About Us

Vanderbilt Report: Coeptis / Z Squared Merger Enters Final Stretch - Closing Imminent as Institutional Tailwinds Build

March 09, 2026

Via ACCESS Newswire

Performance

52-Week Range 23.4% below 52-week high

16.40

9.7852W Low 21.4152W High

Coeptis Therapeutics Holdings, Inc. - Common Stock (COEP) traded between $9.78 and $21.41 over the past 52 weeks and last traded at $16.40, 23.4% below its 52-week high.

Past 12 Months

N/A

+40.3%

+12.0%

-1.3%

6M +$4.71

YTD +$1.76

1Y -$0.22

COEP was -1.3% over the past year, +40.3% over six months, +12.0% year to date.

12 Months vs Market

COEP

-1.3%

DIA

+9.9%

SPY

+15.0%

QQQ

+23.7%

IWM

+15.4%

Over the past 12 months COEP returned -1.3% versus DIA (Dow) +9.9%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +23.7% and IWM (Russell 2000) +15.4%.

Volume & Liquidity

61.1K

YTD

52.4K

58.9K

More News

Coeptis Receives Shareholder Approval Towards Z Squared Merger

February 05, 2026

Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared

January 06, 2026

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates BFIN, COEP, ARIS, CIO on Behalf of Shareholders

Three Biotech Companies Redefining Value Creation Through Dual Strategies

October 14, 2025

Via ACCESS Newswire

October 07, 2025

Coeptis Anchors $800M Valuation in Dual-Sector Strategy; Vanderbilt Report Publishes Coverage

October 01, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 24, 2025

Via Benzinga

Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd

July 22, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, COEP, AVDX on Behalf of Shareholders

July 05, 2025

Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared

June 26, 2025

Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology

May 28, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Skechers U.S.A., Inc. (NYSE - SKX), BioSig Technologies, Inc. (Nasdaq – BSGM), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.

May 05, 2025

From Brodsky & Smith LLC

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COEP and PPBI on Behalf of Shareholders

May 01, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.

May 01, 2025

From Brodsky & Smith LLC

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COEP, SWTX, CKPT on Behalf of Shareholders

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 30, 2025

Via Benzinga

April 30, 2025

COEP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Coeptis Therapeutics Holdings, Inc. Is Fair to Shareholders

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 25, 2025

Via Benzinga

Crude Oil Edges Higher; Phillips 66 Posts Wider-Than-Expected Loss ↗

April 25, 2025

Via Benzinga

April 25, 2025

Via Business Wire

Dow Falls 200 Points; Alphabet Posts Upbeat Q1 Results ↗

April 25, 2025

Via Benzinga

Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement

April 25, 2025

COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology

COEPTIS (COEP) Expands Global Footprint with Strategic India Tech Hub

April 22, 2025

Via AB Newswire

April 17, 2025